Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Embecta Corp.

EMBCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$10.57
$-0.16(-1.49%)
U.S. Market opens in 17h 26m

Embecta Corp. (EMBC) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap626M
P/E Ratio4.47
EPS (TTM)$2.36
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$9.99
3 Months$5.14
1 Year Target$11.19

EMBC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.19.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.47 and a market capitalization of 626M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.90%
5-Day Change
7.09%
1-Month Change
-12.69%
3-Month Change
-21.85%
6-Month Change
-22.75%
Year-to-Date (YTD) Change
-7.98%
1-Year Change
-25.54%
3-Year Change
-65.62%
5-Year Change
-77.17%
All-Time (Max) Change
-77.17%

Contact Information

201 847 6880
300 Kimball Drive, Parsippany, NJ, 07054

Company Facts

20,000 Employees
IPO DateMar 22, 2022
CountryUS
Actively Trading

Frequently Asked Questions